Fate Therapeutics
FATE
FATE
233 hedge funds and large institutions have $2.69B invested in Fate Therapeutics in 2022 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 96 increasing their positions, 70 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more ownership
Funds ownership: →
less funds holding
Funds holding: →
10% less funds holding in top 10
Funds holding in top 10: 10 → 9 (-1)
31% less capital invested
Capital invested by funds: $3.92B → $2.69B (-$1.23B)
34% less first-time investments, than exits
New positions opened: 25 | Existing positions closed: 38
Holders
233
Holding in Top 10
9
Calls
$4.17M
Puts
$3.19M
Top Buyers
| 1 | +$101M | |
| 2 | +$49.6M | |
| 3 | +$23.7M | |
| 4 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
+$20.5M |
| 5 |
AG
Artal Group
Luxembourg
|
+$16.6M |
Top Sellers
| 1 | -$35.9M | |
| 2 | -$26.7M | |
| 3 | -$7.38M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.57M |
| 5 |
AWA
Artemis Wealth Advisors
New York
|
-$3.88M |